U.S., Jan. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07352982) titled 'Transcutaneous Tibial Nerve Stimulation on Women With Primary Dysmenorrhea' on Jan. 13.
Brief Summary: This study aims to investigate the effects of transcutaneous tibial nerve stimulation (TTNS) on women with primary dysmenorrhea (PD).
Study Start Date: Jan. 27
Study Type: INTERVENTIONAL
Condition:
Transcutaneous Tibial Nerve Stimulation
Women
Primary Dysmenorrhea
Intervention:
OTHER: Transcutaneous tibial nerve stimulation (TTNS)
Patients will receive the transcutaneous tibial nerve stimulation (TTNS) and traditional treatment (Nonsteroidal anti-inflammatory drugs) for three sessions a week for four consecutive weeks.
DRUG...